Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Unique human case of T. evansi reported
t. evansi
Responsive animal sampling in the presumed area of exposure uncovered a widespread, previously unidentified burden of T. evansi in local cattle.

Further tests reveal widespread burden in local cattle
 
The first lab-confirmed case of Trypanosoma evansi infection has been reported in a previously healthy individual with no deficiencies.

Cattle and/or buffalo are thought to be the most likely source of infection, according to a report published in the journal Clinical and Infectious Diseases.

The patient, a 38-year-old woman with no Apolipoprotein L1 deficiency, presented at a southern Vietnam healthcare facility in March 2015 with fever, headache and joint pain.

Initial microscopic examination of blood revealed a trypanosoma infection and further PCR and serological testing identified T. evansi.

Although the patient relapsed six weeks after amphotericin B therapy, she made a complete recovery after five weeks of suramin.

Researchers say the infection was potentially contracted via a wound whilst the patient was butchering raw beef.

Responsive animal sampling in the presumed area of exposure uncovered a widespread, previously unidentified burden of T. evansi in local cattle. Nearly half (47%) of animal blood samples tested PCR positive for the infection.

The case highlights the possibility of further human cases and underlines the importance of surveillance for the infection in animals.

The full report can be found here: https://cid.oxfordjournals.org/content/early/2016/02/07/cid.ciw052.abstract

Image credit: Alan R Walker/ Wikimedia Commons/CC BY 3.0

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'